Asprant Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.16 M
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
- Revenue Growth 6.66%
- Profit Growth -7.48%
- Ebitda 98.70%
- Net Worth 33.06%
- Total Assets 17.34%
About Asprant Life Science
Asprant Life Science Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 May 2018 (Six years and nine months 5 days old ). Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.16 M.
The company currently has active open charges totaling ₹2.00 M.
Raju Talukdar, Santanu Chakraborty, and Sutapa Chakraborty serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24299WB2018PTC226270
- Company No.
226270
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 May 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Asprant Life Science?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raju Talukdar  | Director | 15-Dec-2022 | Current |
| Santanu Chakraborty | Director | 01-Feb-2022 | Current |
| Sutapa Chakraborty | Director | 01-Dec-2018 | Current |
Financial Performance of Asprant Life Science.
Asprant Life Science Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.66% increase. The company also saw a slight decrease in profitability, with a 7.48% decrease in profit. The company's net worth Soared by an impressive increase of 33.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asprant Life Science?
In 2021, Asprant Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ableho Agencies LlpSantanu Chakraborty and Sutapa Chakraborty are mutual person
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Feb 2024 | Others | ₹2.00 M | Open |
How Many Employees Work at Asprant Life Science?
Asprant Life Science has a workforce of 10 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asprant Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asprant Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
